ArticlePLoS neglected tropical diseases2025
A comprehensive murine clinical model for development of countermeasures and studying Mayaro virus infection.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mayaro virus (MAYV) is an arthropod-borne virus that causes Mayaro fever, a neglected tropical disease that produces disabling arthralgia. Given the significant threat the dissemination of MAYV poses to global public health, the development of animal models for the Mayaro fever could help elucidate its pathogenic mechanisms and routes of transmission and support the production of prophylactic and therapeutical agents. Thus, this work aimed to characterize a susceptible murine model for MAYV infection. Type I IFN receptor knockout (A129 KO) and wild-type 129S1 mice (A129 WT), 21 days old and from both sexes, were inoculated with the MT/SINOP/210/2011 Brazilian MAYV strain in the footpad, with phosphate-buffered saline-inoculated animals as controls. Clinical signs of infection, survival, body temperature, weight loss, paw swelling, hematological changes, viral load in solid organs and serum, as well as histopathological changes in the tibiotarsal joints were evaluated. MAYV animal models have not been extensively studied using the hypernociception and loss of muscle strength analysis system, therefore we also performed the Von Frey and Kondziella tests. MAYV infection triggered a systemic disease in KO male mice, while local pain and loss of muscle strength were more evident in females. Survival was lower in the KO group than in the WT animals. Both the Von Frey and Kondziella tests showed superior sensitivity in detecting local clinical signs of infection compared to footpad thickness measurements. A marked lymphocytic inflammatory response was observed in the tibiotarsal joints of KO animals, who had increased footpad thickness compared to the WT group. Higher viral titers were detected in the joints and associated muscles of KO mice compared to the WT group at 3 d.p.i., as well as in the brain and gonads of WT and KO animals at 6 d.p.i. In conclusion, we demonstrated that A129 KO mice are efficient in replicating the main clinical signs of the disease caused by Mayaro virus. The Brazilian strain might be neuropathogenic and sexually transmitted, showing that the Mayaro fever might be a serious health care concern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.